The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA's confusing warning letters fda warning bpc 157 peptide products New Details 157 FDA Sends 30 Warning Letters To Continue Clampdown on Compounded GLP 1s BioSpace FDA Moves to Reevaluate Several Peptides American Med Spa Association